Skip to main content
Huberman Lab

Essentials: The Science & Treatment of Obsessive Compulsive Disorder (OCD)

35 min episode · 2 min read

Episode

35 min

Read time

2 min

Topics

Health & Wellness, Psychology & Behavior, Science & Discovery

AI-Generated Summary

Key Takeaways

  • OCD Compulsion Loop: Every time a compulsion is performed to relieve an obsession, the obsession strengthens rather than weakens. This self-reinforcing cycle is the core mechanism of OCD. Understanding this loop explains why avoidance-based coping strategies fail and why treatment must target the compulsion response directly, not just the intrusive thought.
  • CBT Superiority Over SSRIs: Exposure-based cognitive behavioral therapy, conducted twice weekly for 10–12 weeks, reduced Yale-Brown OCD Scale scores from 25 to 11 within four weeks — a larger reduction than SSRIs alone. Combining SSRIs with CBT produced no additional benefit beyond CBT alone, making CBT the primary evidence-based treatment to pursue first.
  • Exposure Therapy Mechanism: Effective CBT for OCD requires identifying the patient's single most catastrophic fear driving the obsession, then progressively inducing maximum anxiety while blocking the compulsive response. This disrupts the corticostriatothalamic circuit by teaching the brain that anxiety can exist without requiring a compulsive behavioral release.
  • SSRIs and Serotonin Paradox: SSRIs reduce OCD symptoms more than placebo, yet there is little evidence that serotonin dysregulation causes OCD. The corticostriatothalamic circuit — involving cortex, striatum, and thalamus — is the primary driver. This means serotonin-targeting drugs work indirectly, and patients should not rely on SSRIs as a standalone or first-line treatment.
  • Inositol as Supplemental Support: Myoinositol at 900mg or higher dosages shows evidence of reducing anxiety and improving sleep, making it a candidate nutraceutical to explore alongside behavioral therapies for OCD. Researchers recommend studying these supplements at lower dosages in combination with CBT rather than as standalone interventions, following the same combinatory logic applied to SSRIs.

What It Covers

Andrew Huberman examines the neuroscience of OCD, affecting 2.5–4% of the population and ranked 7th among the world's most debilitating illnesses. He details the corticostriatothalamic brain circuit driving obsessions and compulsions, then compares treatment effectiveness across CBT, SSRIs, TMS, cannabis, meditation, and nutraceuticals.

Key Questions Answered

  • OCD Compulsion Loop: Every time a compulsion is performed to relieve an obsession, the obsession strengthens rather than weakens. This self-reinforcing cycle is the core mechanism of OCD. Understanding this loop explains why avoidance-based coping strategies fail and why treatment must target the compulsion response directly, not just the intrusive thought.
  • CBT Superiority Over SSRIs: Exposure-based cognitive behavioral therapy, conducted twice weekly for 10–12 weeks, reduced Yale-Brown OCD Scale scores from 25 to 11 within four weeks — a larger reduction than SSRIs alone. Combining SSRIs with CBT produced no additional benefit beyond CBT alone, making CBT the primary evidence-based treatment to pursue first.
  • Exposure Therapy Mechanism: Effective CBT for OCD requires identifying the patient's single most catastrophic fear driving the obsession, then progressively inducing maximum anxiety while blocking the compulsive response. This disrupts the corticostriatothalamic circuit by teaching the brain that anxiety can exist without requiring a compulsive behavioral release.
  • SSRIs and Serotonin Paradox: SSRIs reduce OCD symptoms more than placebo, yet there is little evidence that serotonin dysregulation causes OCD. The corticostriatothalamic circuit — involving cortex, striatum, and thalamus — is the primary driver. This means serotonin-targeting drugs work indirectly, and patients should not rely on SSRIs as a standalone or first-line treatment.
  • Inositol as Supplemental Support: Myoinositol at 900mg or higher dosages shows evidence of reducing anxiety and improving sleep, making it a candidate nutraceutical to explore alongside behavioral therapies for OCD. Researchers recommend studying these supplements at lower dosages in combination with CBT rather than as standalone interventions, following the same combinatory logic applied to SSRIs.

Notable Moment

Despite widespread public enthusiasm for cannabis and CBD as anxiety-reducing tools, a controlled human laboratory study by Columbia's Dr. Helen Blair Simpson found that smoked cannabis — whether THC-dominant or CBD-dominant — produced smaller anxiety reductions than placebo in OCD patients, with no meaningful symptom improvement.

Know someone who'd find this useful?

Episode Transcript

Welcome to Huberman Lab Essentials, where we revisit past episodes for the most potent and actionable science based tools for mental health, physical health, and performance. I'm Andrew Huberman, and I'm a professor of neurobiology and ophthalmology at Stanford School of Medicine. Today, we are talking about obsessive compulsive disorder or OCD. First of all, as the name suggests, OCD includes thoughts or obsessions and compulsions, which are actions. The obsessions and the compulsions are often linked. In fact, most of the time, the obsessions and the compulsions are linked such that the compulsion, the behavior, is designed to relieve the obsession. However, one of the hallmark themes of obsessive compulsive disorder is that the obsessions are intrusive. People don't want to have them. They don't enjoy having them. They just seem to pop into people's minds, and they seem to pop into their mind recurrently. And the compulsions, unlike other sorts of behaviors, provide brief relief to the obsession, but then very quickly reinforce or strengthen the obsession. OCD is extremely common. In fact, current estimates are that anywhere from two point five percent to as high as three or even four percent of people suffer from true OCD. That is an astonishingly high number. Another thing to point out is that OCD is currently listed as number seven in terms of the most debilitating illnesses, not just mental illnesses or disorders, but all types of illnesses, including things like asthma and cancer, etcetera. So you can imagine with that standing at number seven that it is both extremely common and extremely debilitating. And as a consequence, it's now realized that many hours, days, weeks, months, or even years of work performance or showing up at work of relational interactions really suffer as a consequence of people having OCD. With recurrent intrusive thoughts happening at very high frequency or even at moderate frequency, people are spending a lot of time thinking about this stuff, and they're thinking about the behaviors they need to engage in and then engaging in the behaviors, which as I mentioned before, just serve to strengthen the compulsions. And so they're not actually doing the other things that make us functional human beings, like commuting to work or doing homework or doing work or listening when people are talking or interacting or sports or working. Out. All the things that make for a rich quality life are taken over by OCD in many cases. Another thing you'll soon learn is that, sadly, a lot of the obsessions and compulsions in OCD often relate to taboo topics, and that's because the general categories of OCD fall into three different bins. Checking obsessions and compulsions, repetition obsessions and compulsions, and order obsessions and compulsions. The checking ones are somewhat obvious, checking the locks. Repetition obsessions and compulsions obviously can dovetail with the the checking ones, but those tend to be things like counting off of a certain number of numbers, like one, two, three, four, five, six, …

Get the full transcript (6,230 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all Huberman Lab transcripts →

You just read a 3-minute summary of a 32-minute episode.

Get Huberman Lab summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

Books, tools, and gear mentioned in this episode

SignalCast may earn commission on purchases via these links. As an Amazon Associate, SignalCast earns from qualifying purchases.

Products

  • by Eight Sleep

    SPONSORS: Eight Sleep, url: https://8sleep.com/huberman
  • by Aurora Water Filters

    SPONSORS: Aurora Water Filters, url: https://rorra.com/huberman
  • by AG1

    SPONSORS: AG1, url: https://drinkag1.com/huberman

More from Huberman Lab

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best Health Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into Huberman Lab.

Every Monday, we deliver AI summaries of the latest episodes from Huberman Lab and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime